Stock listing
BX Swiss:DOCS Doximity, Inc. Aktie
Swiss listing (BX Swiss) of Doximity, Inc. · home listing NYSE:DOCS
Follow Doximity, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:DOCS
$28.73 USD -1.94 (-6.3%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:DOCS
- Day range
- $28.55 – $29.86 USDNov 20, 2026
- Volume
- 2.38M sharesNov 20, 2026
- Market cap
- $3.66B USDAt the close on Nov 20, 2026 · price × 127.3M shares outstanding
- 52-week range
- $17.15 – $51.85 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $79.74M USDMedian day 2.56M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:DOCS · Home | $28.73 USD | -1.94 (-6.3%) | 2,379,982 | $29.32 | $29.86 | $28.55 | $30.67 | Close on Nov 20, 2026 |
| B3:D2OC34 | 29.88 BRL | 0.00 (0.0%) | — | 29.88 | 29.88 | 29.88 | 29.88 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:DOCS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $28.73 | -1.94 | -6.3% | $29.32 | $29.86 | $28.55 | 2,379,982 | |
| $30.67 | -0.44 | -1.4% | $31.23 | $31.85 | $30.15 | 2,270,165 | |
| $31.11 | -1.66 | -5.1% | $32.37 | $32.44 | $30.71 | 2,763,623 | |
| $32.77 | -0.57 | -1.7% | $33.31 | $33.32 | $32.13 | 1,805,761 | |
| $33.34 | +0.14 | +0.4% | $33.51 | $33.70 | $32.79 | 1,395,927 | |
| $33.20 | -0.02 | -0.1% | $32.97 | $33.89 | $32.82 | 1,950,047 | |
| $33.22 | +0.80 | +2.5% | $32.36 | $33.63 | $31.96 | 2,277,622 | |
| $32.42 | -0.45 | -1.4% | $32.49 | $32.79 | $31.87 | 2,134,197 | |
| $32.87 | +0.36 | +1.1% | $32.24 | $33.09 | $31.92 | 3,072,633 | |
| $32.51 | -0.67 | -2.0% | $30.26 | $32.62 | $29.80 | 4,292,922 | |
| $33.18 | -1.49 | -4.3% | $34.76 | $35.11 | $32.96 | 2,651,377 | |
| $34.67 | +2.07 | +6.3% | $33.10 | $34.92 | $32.92 | 2,901,942 | |
| $32.60 | -0.27 | -0.8% | $32.38 | $33.08 | $32.00 | 2,152,161 | |
| $32.87 | +0.11 | +0.3% | $32.89 | $33.74 | $32.80 | 1,773,428 | |
| $32.76 | -0.87 | -2.6% | $33.48 | $33.89 | $32.49 | 2,202,226 | |
| $33.63 | -0.62 | -1.8% | $33.94 | $34.80 | $33.60 | 2,726,025 | |
| $34.25 | +1.01 | +3.0% | $32.74 | $34.25 | $32.68 | 1,995,405 | |
| $33.24 | +0.16 | +0.5% | $33.00 | $33.25 | $32.45 | 2,005,519 | |
| $33.08 | -0.31 | -0.9% | $33.30 | $33.99 | $32.85 | 2,245,537 | |
| $33.39 | -0.29 | -0.9% | $33.55 | $33.80 | $33.22 | 1,572,176 | |
| $33.68 | +0.10 | +0.3% | $33.58 | $34.16 | $33.37 | 2,846,506 | |
| $33.58 | +0.23 | +0.7% | $33.04 | $34.28 | $33.04 | 2,900,290 | |
| $33.35 | +1.90 | +6.0% | $31.96 | $34.10 | $31.82 | 4,356,183 | |
| $31.45 | +0.48 | +1.5% | $30.80 | $31.57 | $30.59 | 2,027,872 | |
| $30.97 | -0.53 | -1.7% | $31.97 | $32.11 | $30.59 | 3,582,700 | |
| $31.50 | +1.58 | +5.3% | $29.75 | $31.54 | $29.62 | 3,132,700 | |
| $29.92 | -0.63 | -2.1% | $31.13 | $31.13 | $29.68 | 2,693,300 | |
| $30.55 | -0.03 | -0.1% | $30.68 | $31.21 | $30.35 | 2,961,600 | |
| $30.58 | +0.08 | +0.3% | $30.64 | $30.92 | $30.20 | 3,392,800 | |
| $30.50 | +1.12 | +3.8% | $29.45 | $30.50 | $29.17 | 4,941,500 | |
| $29.38 | +1.69 | +6.1% | $27.72 | $29.49 | $27.72 | 5,196,300 | |
| $27.69 | -0.10 | -0.4% | $27.62 | $28.28 | $27.52 | 2,389,100 | |
| $27.79 | -0.79 | -2.8% | $29.06 | $29.20 | $27.71 | 2,309,800 | |
| $28.58 | +0.65 | +2.3% | $28.01 | $28.90 | $28.01 | 3,164,000 | |
| $27.93 | -0.57 | -2.0% | $28.93 | $29.20 | $27.80 | 2,672,100 | |
| $28.50 | +0.16 | +0.6% | $28.91 | $28.95 | $28.07 | 3,340,600 | |
| $28.34 | +1.82 | +6.9% | $26.71 | $28.63 | $26.68 | 4,955,400 | |
| $26.52 | +0.32 | +1.2% | $26.33 | $27.01 | $25.84 | 3,269,300 | |
| $26.20 | -0.15 | -0.6% | $26.04 | $26.71 | $25.33 | 3,035,500 | |
| $26.35 | +0.31 | +1.2% | $25.93 | $26.62 | $25.72 | 2,006,100 | |
| $26.04 | -0.53 | -2.0% | $26.47 | $26.96 | $26.03 | 2,470,500 | |
| $26.57 | +0.06 | +0.2% | $26.64 | $27.00 | $26.35 | 2,473,900 | |
| $26.51 | -0.33 | -1.2% | $27.27 | $27.48 | $26.23 | 2,407,500 | |
| $26.84 | +0.73 | +2.8% | $26.50 | $26.86 | $26.30 | 2,622,900 | |
| $26.11 | -0.46 | -1.7% | $26.55 | $26.86 | $25.95 | 7,207,100 | |
| $26.57 | +0.63 | +2.4% | $26.02 | $26.61 | $25.56 | 2,171,200 | |
| $25.94 | +0.13 | +0.5% | $25.56 | $26.42 | $25.53 | 2,306,400 | |
| $25.81 | -0.58 | -2.2% | $26.02 | $26.83 | $25.57 | 2,558,800 | |
| $26.39 | +0.81 | +3.2% | $26.37 | $26.72 | $25.81 | 2,405,800 | |
| $25.58 | +0.87 | +3.5% | $24.70 | $25.73 | $24.70 | 2,696,100 | |
| $24.71 | +0.52 | +2.1% | $24.10 | $25.04 | $24.07 | 3,176,700 | |
| $24.19 | -0.23 | -0.9% | $24.36 | $24.57 | $23.96 | 2,615,000 | |
| $24.42 | -1.93 | -7.3% | $25.64 | $25.67 | $24.36 | 3,181,200 | |
| $26.35 | -0.75 | -2.8% | $26.77 | $27.03 | $26.31 | 1,984,200 | |
| $27.10 | +0.78 | +3.0% | $26.70 | $27.32 | $26.50 | 2,524,200 | |
| $26.32 | -0.03 | -0.1% | $26.26 | $27.00 | $26.20 | 1,977,600 | |
| $26.35 | -0.36 | -1.3% | $26.33 | $27.03 | $26.21 | 2,029,400 | |
| $26.71 | -0.02 | -0.1% | $25.84 | $26.85 | $25.84 | 2,194,200 | |
| $26.73 | +1.14 | +4.5% | $25.61 | $26.87 | $25.33 | 3,288,600 | |
| $25.59 | +0.85 | +3.4% | $25.13 | $25.81 | $24.89 | 2,466,500 | |
| $24.74 | 0.00 | 0.0% | $24.50 | $25.20 | $24.48 | 1,888,800 | |
| $24.74 | -0.56 | -2.2% | $24.95 | $25.35 | $24.60 | 1,727,544 | |
| $25.30 | -0.03 | -0.1% | $25.34 | $26.08 | $25.10 | 2,869,412 | |
| $25.33 | -0.61 | -2.4% | $25.84 | $25.87 | $25.12 | 2,676,600 | |
| $25.94 | +0.19 | +0.7% | $25.63 | $26.46 | $25.18 | 2,562,700 |
- Ticker
- BX Swiss:DOCS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Nov 13, 2026
Doximity to Provide New Clinical AI Tools Across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine
Latest earnings call · Nov 5, 2026
Doximity (NYSE:DOCS) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q2 2027 Earnings Presentation
Earnings · 24 slides
Latest news
Doximity to Provide New Clinical AI Tools Across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine
Nov 13, 2026
Closed $33.34 (+0.4%) on Nov 13, 2026
More Than Half of U.S. Physicians Now Use AI In Their Practice Daily, But Few Have Clear Rules For It
Nov 12, 2026
Closed $33.20 (-0.1%) on Nov 12, 2026
Quarterly Report for Quarter Ending September 30, 2026 (Form 10-Q)
Nov 5, 2026
Closed $32.51 (-2.0%) on Nov 6, 2026
Doximity Announces Fiscal 2027 Second Quarter Financial Results
Nov 5, 2026
Closed $32.51 (-2.0%) on Nov 6, 2026
Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors
Oct 29, 2026
Closed $33.63 (-1.8%) on Oct 29, 2026
Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask
Oct 20, 2026
Closed $33.35 (+6.0%) on Oct 20, 2026
Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026
Oct 15, 2026
Closed $30.97 (-1.7%) on Oct 16, 2026
Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors
Oct 13, 2026
Closed $30.55 (-0.1%) on Oct 13, 2026
Doximity Named Leading Clinical AI Benchmark in Fireworks’ Cross-Industry Index
Sep 22, 2026
Closed $26.57 (+0.2%) on Sep 23, 2026
Overworked Doctors Bet on AI to Boost Their Pay
Aug 25, 2026
Closed $24.74 (-2.2%) on Aug 25, 2026
Doximity, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 22 in the last 12 months · 31 in all · newest Nov 13, 2026 · oldest 2025
- Calls
- 22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
- Decks
- 21 decks · latest Nov 5, 2026
Where Doximity, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:DOCS · Home listing | NYSE | United States | USD |
| B3:D2OC34 | B3 | Brazil | BRL |
| BOATS:DOCS | BOATS | United States | USD |
| BX Swiss:DOCS · This page | BX Swiss | Switzerland | CHF |
| BMV:DOCS1 | BMV | Mexico | MXN |
| BIVA:DOCS1 | BIVA | Mexico | MXN |
Valuation
P/E 26.2× against a median of 57.5×: 3rd lowest of 8 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.95B USD
- P/E
- 26.2×
- EV/sales
- 4.5×
- EV/EBITDA
- 15.3×
- Price/book
- 3.9×
- Gross margin
- 86.8%
- Operating margin
- 26.3%
- Net margin
- 21.1%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.74
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Doximity, Inc. · NYSE:DOCS | US$3.66B | US$2.95B | 26.2× | 4.5× | 15.3× | 3.9× | 21.1% | 0.0× | 0.74 |
| Global Health Limited · NSE:MEDANTA | US$4.29B | US$4.28B | 64.3× | 7.9× | 35.5× | 9.2× | 12.2% | 0.3× | n/a |
| Narayana Hrudayalaya Ltd. · NSE:NH | US$4.26B | US$4.59B | 46.0× | 4.1× | 22.4× | 7.9× | 8.4% | 1.2× | n/a |
| Bumrungrad Hospital Public Co., Ltd. · SET:BH | US$4.17B | US$3.96B | 18.6× | 5.3× | 13.5× | 5.2× | 29.8% | 0.0× | n/a |
| Jointown Pharmaceutical Group Co., Ltd. Class A · SSE:600998 | US$3.91B | US$755.9M | 13.3× | 0.0× | n/a | 0.9× | 1.1% | 0.1× | n/a |
| Dr. Lal PathLabs Limited · NSE:LALPATHLAB | US$3.62B | US$3.47B | 57.5× | 10.6× | 36.0× | 12.2× | 19.2% | 0.1× | n/a |
| Krishna Institute of Medical Sciences Limited · NSE:KIMS | US$3.61B | US$3.93B | 157× | 7.9× | 41.0× | 8.5× | 4.6% | 0.9× | n/a |
| Surgery Partners, Inc. · NASDAQ:SGRY | US$3.50B | US$6.21B | n/a | 1.9× | 11.5× | 2.1× | −2.6% | 1.8× | 0.94 |
| Hims & Hers Health, Inc. · NYSE:HIMS | US$3.30B | US$4.15B | n/a | 1.4× | n/a | 9.3× | −6.7% | 4.4× | 2.64 |
| Acadia Healthcare Company, Inc. · NASDAQ:ACHC | US$3.22B | US$5.41B | n/a | 1.6× | 10.1× | 1.6× | −33.1% | 1.2× | 0.82 |
| Privia Health Group, Inc. · NASDAQ:PRVA | US$3.20B | US$2.76B | 92.1× | 1.1× | 43.3× | 3.9× | 1.4% | 0.0× | 0.23 |
| Median of the others | US$3.61B | US$4.05B | 57.5× | 3.0× | 29.0× | 6.6× | 3.0% | 0.6× | 0.88 |
Forecasts
3 strong buy · 5 buy · 11 hold · 1 sell · 1 strong sell · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 31.50 USD · Analysts' mean
- EPS, year to Mar 2027
- 1.35 · 18 analysts
- Revenue, year to Mar 2027
- 680.3M · 20 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jeff Tangney | CEO |
| Matt Sonefeldt | Chief Financial Officer |
| Steven L. Zatz | President |
| Ben Greenberg | SVP, GM Commercial Products |
| Bruno Miranda | SVP Engineering |
| Joel Davis | SVP Product |
| JR Ordonez | SVP Design |
| Amit Phull | Chief Medical Officer |
| Jey Balachandran | Chief Technology Officer |
| Lisa Greenbaum | Chief Commercial Officer |
| Nate Gross | Co-Founder |
Board
| Director | Role |
|---|---|
| Kevin Spain | Board Member |
| Kira Wampler | Board Member |
| Phoebe Yang | Board Member |
| Regina Benjamin | Board Member |
| Tim Cabral | Board Member |
Events
Calls
| Call | When | Status |
|---|---|---|
| Doximity (NYSE:DOCS) Q2 2027 Earnings Call | Thu, Nov 05, 2026 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q1 2027 Earnings Call | Thu, Aug 06, 2026 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q4 2026 Earnings Call | Wed, May 13, 2026 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q3 2026 Earnings Call | Thu, Feb 05, 2026 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q2 2026 Earnings Call | Thu, Nov 06, 2025 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q1 2026 Earnings Call | Thu, Aug 07, 2025 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q4 2025 Earnings Call | Thu, May 15, 2025 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q3 2025 Earnings Call | Thu, Feb 06, 2025 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q2 2025 Earnings Call | Thu, Nov 07, 2024 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q1 2025 Earnings Call | Thu, Aug 08, 2024 · 5:00 PM ET | Replay |
All 22 calls
| Call | When | Status |
|---|---|---|
| Doximity (NYSE:DOCS) Q4 2024 Earnings Call | Thu, May 16, 2024 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q3 2024 Earnings Call | Thu, Feb 08, 2024 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q2 2024 Earnings Call | Thu, Nov 09, 2023 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q1 2024 Earnings Call | Tue, Aug 08, 2023 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q4 2023 Earnings Call | Tue, May 16, 2023 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q3 2023 Earnings Call | Thu, Feb 09, 2023 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q2 2023 Earnings Call | Thu, Nov 10, 2022 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q1 2023 Earnings Call | Thu, Aug 04, 2022 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q4 2022 Earnings Call | Tue, May 17, 2022 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q3 2022 Earnings Call | Tue, Feb 08, 2022 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q2 2021 Earnings Call | Tue, Nov 09, 2021 · 5:00 PM ET | Replay |
| Doximity (NYSE:DOCS) Q1 2021 Earnings Call | Tue, Aug 10, 2021 · 5:00 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Nov 5, 2026 · After close | −2.0% |
| Q1 2027 | Aug 6, 2026 · After close | +32.6% |
| Q4 2026 | May 13, 2026 · After close | −23.0% |
| Q3 2026 | Feb 5, 2026 · After close | −16.8% |
| Q2 2026 | Nov 6, 2025 · After close | −13.3% |
| Q1 2026 | Aug 7, 2025 · After close | +13.7% |
| Q4 2025 | May 15, 2025 · After close | −10.1% |
| Q3 2025 | Feb 6, 2025 · After close | +36.0% |
| Q2 2025 | Nov 7, 2024 · After close | +34.1% |
| Q1 2025 | Aug 8, 2024 · After close | +38.7% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | May 16, 2024 · After close | +18.1% |
| Q3 2024 | Feb 8, 2024 · After close | +1.2% |
| Q2 2024 | Nov 9, 2023 · After close | +16.2% |
| Q1 2024 | Aug 8, 2023 · After close | −22.8% |
| Q4 2023 | May 16, 2023 · After close | −5.7% |
| Q3 2023 | Feb 9, 2023 · After close | −12.9% |
| Q2 2023 | Nov 10, 2022 · After close | +32.7% |
| Q1 2023 | Aug 4, 2022 · After close | −7.4% |
| Q4 2022 | May 17, 2022 · After close | −10.3% |
| Q3 2022 | Feb 8, 2022 · After close | +24.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2027 Earnings Presentation | Earnings | 24 slides | Nov 5, 2026 |
| Investor Presentation (August 2026) | Investor deck | 25 slides | August 2026 |
| Q4 2026 Earnings Presentation | Earnings | 25 slides | May 13, 2026 |
| Investor Presentation (February 2026) | Investor deck | 24 slides | February 2026 |
| Q2 FY2026 Earnings Presentation | Earnings | 22 slides | November 2025 |
| Q1 2026 Earnings Presentation | Earnings | 22 slides | Aug 7, 2025 |
| Q4 2025 Earnings Presentation | Earnings | 20 slides | May 15, 2025 |
| Q3 FY2025 Earnings Presentation | Earnings | 20 slides | February 2025 |
| Q2 FY2025 Earnings Presentation | Earnings | 20 slides | November 2024 |
| Investor Presentation (August 2024) | Investor deck | 20 slides | August 2024 |
All 21 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Presentation (May 2024) | 5 slides | May 16, 2024 | |
| Investor Presentation (February 2024) | Investor deck | 19 slides | February 2024 |
| Investor Presentation (2023) | Investor deck | 18 slides | Nov 2, 2023 |
| Investor Presentation (November 2023) | Investor deck | 18 slides | November 2023 |
| Investor Presentation (2023) | Investor deck | 18 slides | Jul 5, 2023 |
| Investor Day (June 2023) | Investor day | 56 slides | Jun 6, 2023 |
| Investor Day (June 2023) | Investor day | 47 slides | Jun 6, 2023 |
| Investor Day (June 2023) | Investor day | 55 slides | Jun 6, 2023 |
| Q4 FY2023 Earnings Presentation | Earnings | 18 slides | May 2023 |
| Investor Presentation (2023) | Investor deck | 18 slides | Mar 11, 2023 |
| Investor Presentation (November 2022) | Investor deck | 18 slides | November 2022 |
IPO
Priced at US$26.00 a share on Jun 23, 2021.
- Price
- US$26.00 a share
- Shares offered
- 23,300,000 shares of Class A common stock · 19,010,750 from the company and 4,289,250 from selling shareholders
- Offering size
- US$605.8 million
- Underwriters' option
- Up to 3,495,000 more shares
- Listing
- DOCS on the New York Stock Exchange
- Underwriters
- MORGAN STANLEY, J.P. MORGAN, GOLDMAN SACHS & CO. LLC, PIPER SANDLER, WILLIAM BLAIR, CANACCORD GENUITY, NEEDHAM & COMPANY, RAYMOND JAMES, SVB LEERINK · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 5, 2021 |
| Filed publicly | May 28, 2021 |
| Amended twice | Newest Jun 22, 2021 |
| Shares registered with an exchange | Jun 15, 2021 |
| Declared effective by the SEC | Jun 23, 2021 |
| Final prospectus, with the price | Jun 25, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 25, 2021 |
| EFFECT · Notice that a registration is effective | Jun 23, 2021 |
| CORRESP · Letter to the SEC | Jun 23, 2021 |
| CORRESP · Letter to the SEC | Jun 23, 2021 |
| S-1/A · Registration statement, amended | Jun 22, 2021 |
| CERT · Exchange's certificate of listing | Jun 16, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 15, 2021 |
| S-1/A · Registration statement, amended | Jun 15, 2021 |
| CORRESP · Letter to the SEC | Jun 4, 2021 |
| S-1 · Registration statement | May 28, 2021 |
All 17 filings
| Filing | Filed |
|---|---|
| DRSLTR · Letter to the SEC with a draft | May 7, 2021 |
| DRS/A · Draft registration statement, amended | May 7, 2021 |
| UPLOAD · Letter from the SEC | Apr 30, 2021 |
| DRSLTR · Letter to the SEC with a draft | Apr 16, 2021 |
| DRS/A · Draft registration statement, amended | Apr 16, 2021 |
| UPLOAD · Letter from the SEC | Apr 1, 2021 |
| DRS · Draft registration statement | Mar 5, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Jun 25, 2021
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 644.9M | 570.4M | 475.4M | 419.1M | 343.5M | 206.9M | 116.4M | 85.7M |
| Cost of revenue | 70.3M | 55.9M | 50.7M | 53.5M | 39.8M | 31.2M | 14.9M | 10.9M |
| Gross profit | 574.5M | 514.5M | 424.8M | 365.6M | 303.8M | 175.7M | 101.5M | 74.8M |
| Research and development | 130.7M | 93.0M | 82.0M | 80.2M | 62.4M | 43.9M | 32.4M | 27.5M |
| Selling, general and administrative | 65.3M | 45.7M | 37.8M | 36.7M | 35.7M | 16.5M | 7.44M | 7.34M |
| Operating income | 214.9M | 227.8M | 163.9M | 125.1M | 113.5M | 53.3M | 22.2M | 6.92M |
| Depreciation and amortization | 14.4M | 10.7M | 10.3M | 10.3M | 5.04M | 3.70M | 900.0K | 551.0K |
| EBITDA | 229.3M | 238.5M | 174.1M | 135.4M | 118.6M | 57.0M | 23.1M | 7.47M |
| Interest expense | 8.05M | 469.0K | 4.47M | 1.35M | 1.01M | |||
| Income before tax | 250.0M | 263.6M | 185.2M | 133.2M | 114.0M | 57.8M | 23.5M | 7.93M |
| Income tax | 54.0M | 40.4M | 37.6M | 20.3M | -40.8M | 7.56M | -6.22M | 98.0K |
| Net income | 196.1M | 223.2M | 147.6M | 112.8M | 154.8M | 50.2M | 29.7M | 7.83M |
| Earnings per share, basic | 1.05 | 1.19 | 0.78 | 0.58 | 0.82 | 0.29 | 0.16 | 0.04 |
| Earnings per share, diluted | 0.98 | 1.11 | 0.72 | 0.53 | 0.70 | 0.23 | 0.13 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 219.2M | 209.6M | 96.8M | 158.0M | 112.8M | 66.4M | 48.4M | 33.6M |
| Short-term investments | 529.4M | 706.0M | 666.1M | 683.0M | 685.3M | 76.1M | 38.0M | 28.7M |
| Receivables | 144.8M | 128.4M | 101.3M | 107.0M | 81.1M | 50.3M | 26.2M | 15.3M |
| Inventory | -42.6M | 5.12M | 5.86M | 3.41M | 1 | |||
| Current assets | 944.3M | 1.09B | 912.9M | 975.5M | 904.1M | 209.4M | 123.0M | 83.4M |
| Property, plant and equipment | 18.1M | 13.7M | 12.3M | 11.3M | 8.49M | 7.60M | 7.11M | 1.37M |
| Goodwill | 85.0M | 67.9M | 67.9M | 67.9M | 18.9M | 18.9M | 0 | |
| Total assets | 1.12B | 1.26B | 1.08B | 1.14B | 991.4M | 251.7M | 138.9M | 86.6M |
| Accounts payable | 4.01M | 1.36M | 2.25M | 1.27M | 463.0K | 1.51M | 1.42M | 938.0K |
| Current liabilities | 155.0M | 156.3M | 147.3M | 139.5M | 111.3M | 102.0M | 55.7M | 37.8M |
| Total debt | 10.2M | 12.4M | 14.5M | 15.6M | 1.09M | 1.25M | 2.28M | |
| Total liabilities | 172.8M | 181.7M | 178.0M | 170.8M | 112.8M | 103.5M | 137.8M | 37.8M |
| Shareholders' equity | 950.8M | 1.08B | 901.4M | 966.1M | 878.6M | 66.7M | 1.14M | 48.5M |
| Shares outstanding | 183.1M | 188.9M | 186.6M | 193.9M | 192.4M | 82.9M | 181.7M | 181.7M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 326.5M | 273.3M | 184.1M | 179.6M | 126.6M | 83.0M | 26.2M | 15.3M |
| Capital spending | 0 | 0 | -147.0K | -1.70M | -1.91M | -245.0K | -285.0K | -1.19M |
| Free cash flow | 326.5M | 273.3M | 183.9M | 177.9M | 124.7M | 82.7M | 25.9M | 14.1M |
| Cash from investing | 147.2M | -29.3M | 31.2M | -59.9M | -640.6M | -70.4M | -13.1M | -9.07M |
| Cash from financing | -464.1M | -131.1M | -276.5M | -74.5M | 560.4M | 5.41M | 1.72M | 985.0K |
| Share buybacks | -431.7M | -120.3M | -280.7M | -85.3M | -2.70M | -2.02M | 0 | 0 |
| Change in cash | 9.56M | 112.8M | -61.2M | 45.2M | 46.4M | 18.0M | 14.8M | 7.22M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 5, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 4 · Change in ownership | Nov 4, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Nov 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 14, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 1, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 30, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 2, 2026 | Meeting outcome | SEC |
| 144 · Notice of proposed sale | Sep 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 25, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 7, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 15, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Jul 15, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jul 15, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jul 15, 2026 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Jul 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 9, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 19, 2026 | Offer document | SEC |
| 10-K · Annual report | May 19, 2026 | Annual report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 8-K · Current report | May 13, 2026 | Results | SEC |
| 144 · Notice of proposed sale | May 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 7, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 17, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Apr 14, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 10, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Mar 26, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 23, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 23, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 13, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Feb 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Feb 5, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 5, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 2, 2026 | Other filings | SEC |
| 8-K · Current report | Dec 30, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| 4 · Change in ownership | Nov 5, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Nov 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 10, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 24, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 16, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 2, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Aug 27, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 26, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 15, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 15, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 8, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 7, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 6, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 1, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 1, 2025 | Other filings | SEC |
| ARS · Annual report to shareholders | Jul 16, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jul 16, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jul 16, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 27, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 25, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 25, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 13, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 23, 2025 | Other filings | SEC |
| S-8 · Registration statement for employee plans | May 20, 2025 | Offer document | SEC |
| 10-K · Annual report | May 20, 2025 | Annual report | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 8-K · Current report | May 15, 2025 | Results | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Apr 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 1, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 7, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Feb 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Feb 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 12, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 12, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 12, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Feb 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Feb 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Feb 6, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 5, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Feb 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 15, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 14, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
This page holds 200 of 469 filings. Open Filings
Cap table
Built by 6ix from Doximity, Inc.’s releases
- Common shares
- 127,349,369
- Fully diluted
- 127,349,369
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 127,349,369 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 127,349,369 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gilbert H. Kliman Other companies: Glaukos Corporation (Director · Since at least Jun 24, 2015); STAAR Surgical Company (Director · Jun 1, 2020 – Dec 1, 2023 · Past); Venus Concept Inc (Director · Oct 11, 2017 – Nov 7, 2019 · Past); Epocrates Inc (Director · Feb 1, 2011 – Feb 1, 2011 · Past); Intralase Corp (Director · Jan 5, 2006 – Apr 2, 2007 · Past) | Director · Jun 23, 2021 – Jul 27, 2022 · Past |
| Regina Benjamin Other companies: TruBridge, Inc. (Director · Since at least Mar 15, 2024); Oak Street Health Inc (Director · Apr 28, 2022 – May 2, 2023 · Past) | Board Member · Since at least Jul 27, 2022 |
| Tim Cabral Other companies: ServiceTitan, Inc. (Director · Since at least Dec 11, 2024); Veeva Systems Inc. (Director · Since at least Jun 8, 2016) | Board Member · Since at least Jun 23, 2021 |
| Joseph B Kleine Other companies: Epocrates Inc (EVP & Chief Commercial Officer · Feb 1, 2011 – Mar 24, 2011 · Past) | Chief Commercial Officer · Jun 23, 2021 – Jan 12, 2022 · Past |
| Kevin Spain Other companies: Veeva Systems Inc. (Director · Oct 15, 2013 – Jun 24, 2014 · Past) | Board Member · Since at least Jun 23, 2021 |
| Phoebe Yang Other companies: GE HealthCare Technologies Inc. (Director · Since at least Nov 5, 2026) | Board Member · Since at least Nov 5, 2026 |
| Watkin Phoebe L Yang Other companies: GE HealthCare Technologies Inc. (Director · Since at least Jan 3, 2023) | Director · Since at least Aug 2, 2022 |
| Amit Phull | Chief Medical Officer · Since at least Aug 25, 2026 |
| Anna Bryson | Chief Financial Officer · Since at least Jun 23, 2021 |
| Ben Greenberg | SVP, GM Commercial Products · Since at least Nov 5, 2026 |
All 24 people
| Person | Seat |
|---|---|
| Bruno Miranda | SVP Engineering · Since at least Nov 5, 2026 |
| Craig Overpeck | See Remarks · May 16, 2023 – May 15, 2024 · Past |
| Jeffrey Tangney | Chief Executive Officer, Director · Since at least Feb 16, 2021 |
| Jeff Tangney | CEO · Since at least Aug 17, 2026 |
| Jey Balachandran | Chief Technology Officer · Since at least Nov 5, 2026 |
| Joel Davis | SVP Product · Since at least Nov 5, 2026 |
| JR Ordonez | SVP Design · Since at least Nov 5, 2026 |
| Kira Wampler | Board Member · Since at least Jun 23, 2021 |
| Lisa Greenbaum | Chief Commercial Officer · Since at least Nov 5, 2026 |
| Matt Sonefeldt | Chief Financial Officer · Since at least May 13, 2026 |
| Nate Gross | Co-Founder · Since at least Nov 4, 2026 |
| Paul W Jorgensen | Chief Revenue Officer · Mar 22, 2022 – Feb 15, 2023 · Past |
| Siddharth Sitaram | Chief Accounting Officer · Since at least Feb 3, 2026 |
| Steven L. Zatz | President · Since at least May 13, 2026 |
Log in to ask 6ix AI your own questions about Doximity, Inc.